Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists

Area of Science:

• Medicinal Chemistry
• Neuropharmacology
• Drug Discovery

Background:

• Adenosine A2A receptors are implicated in various neurological processes.
• Developing selective antagonists for A2A receptors is a therapeutic goal.

Purpose of the Study:

• To synthesize and evaluate novel benzyl-substituted thieno[2,3-d]pyrimidine derivatives.
• To identify potent adenosine A2A receptor antagonists with potential therapeutic applications.

Main Methods:

• Synthesis of a series of thieno[2,3-d]pyrimidine compounds.
• Exploration of heterocyclic replacements for a methylfuran moiety.
• In vivo evaluation of compound efficacy in a mouse catalepsy model.

Main Results:

• Identification of potent benzyl-substituted thieno[2,3-d]pyrimidine derivatives as A2A receptor antagonists.
• Several compounds demonstrated significant reversal of catalepsy in mice.
• Oral administration of select compounds proved effective.

Conclusions:

• Benzyl-substituted thieno[2,3-d]pyrimidines represent a promising class of adenosine A2A receptor antagonists.
• These compounds hold potential for the treatment of neurological conditions associated with A2A receptor dysfunction.
• The developed compounds offer a viable therapeutic strategy for conditions like Parkinson's disease.